Mud & Hound PCL (BKK:MUD)

CTI BioPharma Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	60.81	75.46	113.74	224.41	206.47	164.68
Trading Asset Securities	-	-	-	9.2	19.31	-
Cash & Short-Term Investments	60.81	75.46	113.74	233.61	225.78	164.68
Cash Growth	-23.41%	-33.65%	-51.31%	3.47%	37.10%	11.29%
Accounts Receivable	37.65	58.1	60.84	57.61	61.29	47.84
Other Receivables	11.96	10.63	4.96	15.14	14.57	30.62
Receivables	49.61	68.74	65.8	72.75	75.85	78.46
Inventory	168.92	186.22	214.58	200.47	177.74	150.21
Prepaid Expenses	31.2	29.4	33.89	40.49	37.25	51.95
Other Current Assets	31.53	32.04	41.53	32.08	31.17	33.51
Total Current Assets	342.06	391.86	469.53	579.41	547.78	478.81
Property, Plant & Equipment	1,583	1,655	1,968	1,909	1,548	1,497
Goodwill	1,880	1,880	1,940	1,940	1,940	1,940
Other Intangible Assets	609.49	616.46	652.54	677.01	715.33	733.93
Other Long-Term Assets	175.02	171.25	152.91	147.36	145.3	142.29
Total Assets	4,589	4,715	5,183	5,252	4,897	4,792
Accounts Payable	153.89	199.65	248.25	213.21	176.95	144.97
Accrued Expenses	91.05	95.73	98.82	116.45	140.4	89.07
Short-Term Debt	224.67	220.26	253.12	220.69	233.35	175.4
Current Portion of Long-Term Debt	688.59	551.85	114.08	641.08	241.74	421.75
Current Portion of Leases	294.7	312.66	345.41	320.71	198.38	238.73
Current Income Taxes Payable	3.09	1.73	6.24	3.01	2.11	1.55
Current Unearned Revenue	6.72	7.37	6.3	14.79	11.18	25.18
Other Current Liabilities	100.59	120.09	166.75	131.9	127.29	140.72
Total Current Liabilities	1,563	1,509	1,239	1,662	1,131	1,237
Long-Term Debt	647.46	706.74	1,017	527.32	839.26	507.69
Long-Term Leases	472.72	526.14	636.2	732.01	567.41	548.51
Long-Term Deferred Tax Liabilities	110.4	116.44	129.68	123.29	158.82	168.57
Other Long-Term Liabilities	56.66	58.47	60.83	60.02	70.36	71.25
Total Liabilities	2,875	2,941	3,105	3,125	2,787	2,557
Common Stock	1,053	1,053	1,053	1,053	1,053	1,055
Additional Paid-In Capital	1,793	1,793	1,793	1,793	1,953	1,953
Retained Earnings	-1,226	-1,192	-882.18	-870.1	-1,055	-951.52
Treasury Stock	-	-	-	-	-	-3.94
Comprehensive Income & Other	209.99	225.12	198.89	212.34	198.94	212.39
Total Common Equity	1,830	1,879	2,163	2,188	2,151	2,265
Minority Interest	-116.32	-105.61	-84.89	-60.6	-40.94	-29.34
Shareholders' Equity	1,714	1,774	2,078	2,128	2,110	2,236
Total Liabilities & Equity	4,589	4,715	5,183	5,252	4,897	4,792
Total Debt	2,328	2,318	2,366	2,442	2,080	1,892
Net Cash (Debt)	-2,267	-2,242	-2,252	-2,208	-1,854	-1,727
Net Cash Per Share	-2.15	-2.13	-2.14	-2.10	-1.76	-1.64
Filing Date Shares Outstanding	1,053	1,053	1,053	1,053	1,053	1,053
Total Common Shares Outstanding	1,053	1,053	1,053	1,053	1,053	1,053
Working Capital	-1,221	-1,117	-769.46	-1,082	-583.62	-758.55
Book Value Per Share	1.74	1.78	2.05	2.08	2.04	2.15
Tangible Book Value	-659.38	-617.27	-429.62	-428.55	-504.39	-408.63
Tangible Book Value Per Share	-0.63	-0.59	-0.41	-0.41	-0.48	-0.39
Buildings	-	924.99	993.98	19.54	797.72	742.71
Machinery	-	856.4	870.5	1,718	699.1	645.79
Construction In Progress	-	4.49	24.32	31.58	30.38	11.39

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.